120 related articles for article (PubMed ID: 29363569)
1. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia.
Li H; Yao J; Chang X; Wu J; Duan T; Wang K
Reproduction; 2018 Mar; 155(3):297-306. PubMed ID: 29363569
[TBL] [Abstract][Full Text] [Related]
2. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
[TBL] [Abstract][Full Text] [Related]
3. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
[TBL] [Abstract][Full Text] [Related]
4. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
[TBL] [Abstract][Full Text] [Related]
5. A Single Sphingomyelin Species Promotes Exosomal Release of Endoglin into the Maternal Circulation in Preeclampsia.
Ermini L; Ausman J; Melland-Smith M; Yeganeh B; Rolfo A; Litvack ML; Todros T; Letarte M; Post M; Caniggia I
Sci Rep; 2017 Sep; 7(1):12172. PubMed ID: 28939895
[TBL] [Abstract][Full Text] [Related]
6. MMP-14 aggravates onset of severe preeclampsia by mediating soluble endoglin release.
Zhang XH; Zhang HY; Lu S; Jiang LL; Wu J; Yang YL; Zhang SA
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1209-1215. PubMed ID: 29565476
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia.
Liu X; Deng Q; Luo X; Chen Y; Shan N; Qi H
J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3776-85. PubMed ID: 26809169
[TBL] [Abstract][Full Text] [Related]
8. Role of soluble endoglin in BMP9 signaling.
Lawera A; Tong Z; Thorikay M; Redgrave RE; Cai J; van Dinther M; Morrell NW; Afink GB; Charnock-Jones DS; Arthur HM; Ten Dijke P; Li W
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17800-17808. PubMed ID: 31431534
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities.
Pérez-Roque L; Núñez-Gómez E; Rodríguez-Barbero A; Bernabéu C; López-Novoa JM; Pericacho M
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375253
[TBL] [Abstract][Full Text] [Related]
10. Exosomes From Women With Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells.
Chang X; Yao J; He Q; Liu M; Duan T; Wang K
Hypertension; 2018 Dec; 72(6):1381-1390. PubMed ID: 30571229
[TBL] [Abstract][Full Text] [Related]
11. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
Luo X; Liu DD; Qi HB; Yao ZW
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
[TBL] [Abstract][Full Text] [Related]
12. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
13. Oxysterol-induced soluble endoglin release and its involvement in hypertension.
Valbuena-Diez AC; Blanco FJ; Oujo B; Langa C; Gonzalez-Nuñez M; Llano E; Pendas AM; Díaz M; Castrillo A; Lopez-Novoa JM; Bernabeu C
Circulation; 2012 Nov; 126(22):2612-24. PubMed ID: 23110859
[TBL] [Abstract][Full Text] [Related]
14. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
15. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
16. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury.
Gallardo-Vara E; Blanco FJ; Roqué M; Friedman SL; Suzuki T; Botella LM; Bernabeu C
Angiogenesis; 2016 Apr; 19(2):155-71. PubMed ID: 26850053
[TBL] [Abstract][Full Text] [Related]
18. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
[TBL] [Abstract][Full Text] [Related]
19. GNG7 silencing promotes the proliferation and differentiation of placental cytotrophoblasts in preeclampsia rats through activation of the mTOR signaling pathway.
Lai WS; Ding YL
Int J Mol Med; 2019 May; 43(5):1939-1950. PubMed ID: 30864685
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
